Key Details
Price
$126.48Last Dividend
$0.03Annual ROE
12.08%Beta
0.74Events Calendar
Next earnings date:
Feb 07, 2025Recent quarterly earnings:
Oct 29, 2024Recent annual earnings:
Feb 08, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Mar 13, 2000Next split:
N/ARecent split:
Oct 11, 2012Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Tenet Healthcare Corporation has greatly enhanced its financial situation by selling off hospitals and lowering its debt, all while performing well in operations. The company has prioritized quality over expansion, generating significant revenue from Ambulatory Care, which offers better profit margins than Hospital Operations. Following recent drops in share prices due to election results and previous trends, Tenet's strong earnings potential and lower debt levels make it an attractive investment.
Tenet (THC) has received a Zacks Rank #2 (Buy) upgrade, indicating increased confidence in the company's potential earnings. This could lead to a rise in the stock price soon.
Users of Zacks.com have been paying a lot of attention to Tenet (THC) lately. Therefore, it's important to understand the key information that could influence the stock's future.
Are you looking for ways to choose powerful stocks that can outperform the market for your investment portfolio? The Zacks Style Scores can help you with that.
In the latest trading session, Tenet Healthcare (THC) finished at $129.64, showing a slight increase of 0.14% compared to the day before.
In the latest trading session, Tenet Healthcare (THC) finished at $129.64, showing a slight increase of 0.14% compared to the day before.
No matter if you invest in value, growth, or momentum stocks, the Zacks Style Scores can help you identify strong stocks more easily. This is one of the key features of the Zacks Premium research service.
Tenet Healthcare is in a good position for future growth because of the increasing need for healthcare and its focus on cost-effective outpatient services. Their financial results indicate significant growth in revenue and net income, thanks to asset sales, improved operating income, and careful expense management. Ambulatory Surgery Centers are expected to keep growing in revenue and will likely play an important role in Tenet's ongoing success.
At Zacks, we concentrate on the reliable Zacks Rank system, which highlights earnings estimates and changes in those estimates to identify excellent stocks. At the same time, we keep an eye on the most recent trends in value, growth, and momentum to support our top selections.
The strong selling pressure on Tenet (THC) may have lessened, as it is currently considered oversold. Furthermore, the consensus among Wall Street analysts to raise earnings estimates suggests that the stock could be ready for a change in direction.
FAQ
- What is the primary business of Tenet Healthcare?
- What is the ticker symbol for Tenet Healthcare?
- Does Tenet Healthcare pay dividends?
- What sector is Tenet Healthcare in?
- What industry is Tenet Healthcare in?
- What country is Tenet Healthcare based in?
- When did Tenet Healthcare go public?
- Is Tenet Healthcare in the S&P 500?
- Is Tenet Healthcare in the NASDAQ 100?
- Is Tenet Healthcare in the Dow Jones?
- When was Tenet Healthcare's last earnings report?
- When does Tenet Healthcare report earnings?
- Should I buy Tenet Healthcare stock now?